A detailed history of Northern Trust Corp transactions in Liva Nova PLC stock. As of the latest transaction made, Northern Trust Corp holds 632,389 shares of LIVN stock, worth $29.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
632,389
Previous 635,007 0.41%
Holding current value
$29.6 Million
Previous $34.8 Million 4.61%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$43.38 - $54.59 $113,568 - $142,916
-2,618 Reduced 0.41%
632,389 $33.2 Million
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $1.1 Million - $1.36 Million
21,227 Added 3.46%
635,007 $34.8 Million
Q1 2024

May 14, 2024

SELL
$48.6 - $57.12 $2.68 Million - $3.15 Million
-55,166 Reduced 8.25%
613,780 $34.3 Million
Q4 2023

Feb 13, 2024

SELL
$43.45 - $53.66 $326,700 - $403,469
-7,519 Reduced 1.11%
668,946 $34.6 Million
Q3 2023

Nov 13, 2023

SELL
$50.12 - $58.87 $516,085 - $606,184
-10,297 Reduced 1.5%
676,465 $35.8 Million
Q2 2023

Aug 11, 2023

BUY
$42.28 - $51.43 $118,172 - $143,746
2,795 Added 0.41%
686,762 $35.3 Million
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $229,398 - $326,572
-5,617 Reduced 0.81%
683,967 $29.8 Million
Q4 2022

Feb 13, 2023

BUY
$43.88 - $56.16 $475,001 - $607,932
10,825 Added 1.59%
689,584 $38.3 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $458,402 - $630,220
-9,477 Reduced 1.38%
678,759 $34.5 Million
Q2 2022

Aug 12, 2022

SELL
$57.25 - $86.63 $860,696 - $1.3 Million
-15,034 Reduced 2.14%
688,236 $43 Million
Q1 2022

May 13, 2022

SELL
$71.02 - $86.99 $2.21 Million - $2.71 Million
-31,159 Reduced 4.24%
703,270 $57.5 Million
Q4 2021

Feb 08, 2022

SELL
$76.72 - $92.68 $732,752 - $885,186
-9,551 Reduced 1.28%
734,429 $64.2 Million
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $10.5 Million - $12.2 Million
-138,154 Reduced 15.66%
743,980 $58.9 Million
Q2 2021

Aug 13, 2021

BUY
$73.44 - $87.01 $11.9 Million - $14.1 Million
162,389 Added 22.56%
882,134 $74.2 Million
Q1 2021

May 12, 2021

SELL
$62.9 - $82.41 $702,970 - $921,014
-11,176 Reduced 1.53%
719,745 $53.1 Million
Q4 2020

Feb 11, 2021

SELL
$46.01 - $68.74 $1.08 Million - $1.61 Million
-23,444 Reduced 3.11%
730,921 $48.4 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $2.06 Million - $2.85 Million
-49,258 Reduced 6.13%
754,365 $34.1 Million
Q2 2020

Aug 14, 2020

BUY
$39.87 - $56.9 $1.09 Million - $1.55 Million
27,320 Added 3.52%
803,623 $38.7 Million
Q1 2020

May 14, 2020

BUY
$34.22 - $76.49 $79,013 - $176,615
2,309 Added 0.3%
776,303 $35.1 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $965,982 - $1.2 Million
-14,016 Reduced 1.78%
773,994 $58.4 Million
Q3 2019

Nov 13, 2019

BUY
$71.74 - $86.35 $663,379 - $798,478
9,247 Added 1.19%
788,010 $58.1 Million
Q2 2019

Aug 13, 2019

BUY
$66.45 - $97.36 $286,864 - $420,303
4,317 Added 0.56%
778,763 $56 Million
Q1 2019

May 13, 2019

BUY
$86.15 - $100.49 $924,303 - $1.08 Million
10,729 Added 1.4%
774,446 $75.3 Million
Q4 2018

Feb 12, 2019

SELL
$84.14 - $125.42 $296,593 - $442,105
-3,525 Reduced 0.46%
763,717 $69.9 Million
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $4 Million - $5.19 Million
39,608 Added 5.44%
767,242 $95.1 Million
Q2 2018

Sep 18, 2018

SELL
$81.75 - $105.37 $253,833 - $327,173
-3,105 Reduced 0.42%
727,634 $72.6 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $3.25 Million - $4.19 Million
39,727 Added 5.75%
730,739 $72.9 Million
Q1 2018

May 09, 2018

SELL
$79.95 - $89.74 $64,279 - $72,150
-804 Reduced 0.12%
691,012 $61.2 Million
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $1.82 Million - $2.23 Million
-25,301 Reduced 3.53%
691,816 $55.3 Million
Q3 2017

Nov 13, 2017

BUY
$60.32 - $70.06 $43.3 Million - $50.2 Million
717,117
717,117 $50.2 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.